Literature DB >> 6103958

1-(Aminoalkyl)-6-aryl-4-H-s-triazolo[4,3-a][1,4]benzodiazepines with antianxiety and antidepressant activity.

J B Hester, A D Rudzik, P F VonVoigtlander.   

Abstract

A series of 1-(aminoalkyl)-6-aryl-4H-s-triazolo[4,3-a][1,4]benzodiazepines has been prepared and evaluated for central nervous system activity. We have found that members of this series have activity in pharmacological test systems designed to detect both anxiolytic and antidepressant activity. Each type of activity could be varied independently by appropriate substituent selections.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 6103958     DOI: 10.1021/jm00178a009

Source DB:  PubMed          Journal:  J Med Chem        ISSN: 0022-2623            Impact factor:   7.446


  4 in total

1.  Adinazolam, a new triazolobenzodiazepine, and imipramine in the treatment of major depressive disorder.

Authors:  J D Amsterdam; M Kaplan; L Potter; L Bloom; K Rickels
Journal:  Psychopharmacology (Berl)       Date:  1986       Impact factor: 4.530

2.  Targeting S-adenosylmethionine biosynthesis with a novel allosteric inhibitor of Mat2A.

Authors:  Casey L Quinlan; Stephen E Kaiser; Ben Bolaños; Dawn Nowlin; Rita Grantner; Shannon Karlicek-Bryant; Jun Li Feng; Stephen Jenkinson; Kevin Freeman-Cook; Stephen G Dann; Xiaoli Wang; Peter A Wells; Valeria R Fantin; Al E Stewart; Stephan K Grant
Journal:  Nat Chem Biol       Date:  2017-05-29       Impact factor: 15.040

3.  1,4-Benzodiazepine N-nitrosoamidines: useful intermediates in the synthesis of tricyclic benzodiazepines.

Authors:  Santos Fustero; Javier González; Carlos del Pozo
Journal:  Molecules       Date:  2006-08-09       Impact factor: 4.411

4.  Mechanism of triazolo-benzodiazepine and benzodiazepine action in anxiety and depression: behavioral studies with concomitant in vivo CA1 hippocampal norepinephrine and serotonin release detection in the behaving animal.

Authors:  P A Broderick; O Hope; P Jeannot
Journal:  Prog Neuropsychopharmacol Biol Psychiatry       Date:  1998-02       Impact factor: 5.067

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.